Steam vs. pills: new study tests better fix for enlarged prostate in sexually active men

NCT ID NCT04838769

Ongoing Disease control Sponsor: Boston Scientific Corporation Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 13, 2026 · Updated 4 times

Summary

This study compares a minimally invasive water vapor treatment (REZŪM) to taking two drugs together for men with an enlarged prostate that didn't get better with one drug. It includes 155 sexually active men aged 45 and older. The goal is to see which approach better improves urinary symptoms and sexual health.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

benign prostatic hyperplasia Lower Urinary Tract Symptoms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BENIGN PROSTATIC HYPERPLASIA (BPH)

Contacts and locations

Locations

Australian Clinical Trials

Wahroonga, Australia
CHU Grenoble

Grenoble, France
CHU d'Angers

Angers, France
CHU de Bordeaux

Bordeaux, France
CHU de Nice

Nice, France
CHU de Rennes

Rennes, France
CHU de Rouen

Rouen, France
CHU de Toulouse

Toulouse, France
Centre Hospitalier Privé Saint Grégoire

Saint-Grégoire, France
Centre Hospitalier Universitaire de Lille

Lille, France
Centre Hospitalier du Pays d'Aix

Aix-en-Provence, France
Clinique La Croix du Sud

Quint-Fonsegrives, France
Clinique Pasteur

Toulouse, France
Clinique Saint Hilaire

Rouen, France
Epworth Healthcare

Melbourne, Australia
Hospices Civils de Lyon

Lyon, France
Hôpital Bichat

Paris, France
Hôpital Cochin

Paris, France
Hôpital Privé La Louvière

Lille, France
Hôpital privé Francheville

Périgueux, France
Institut Mutualiste Montsouris

Paris, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.